Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

HUMAN IMMUNOGLOBULIN (MOLECULAR SIZE) BRP (10 ML)

HUMAN IMMUNOGLOBULIN (MOLECULAR SIZE) BRP (10 ML)

9007-83-4

DISCOVER
MYCOPHENOLATE MOFETIL CRS (30MG)

MYCOPHENOLATE MOFETIL CRS (30MG)

128794-94-5

DISCOVER
MISOPROSTOL CRS (100 MG)

MISOPROSTOL CRS (100 MG)

59122-46-2

DISCOVER
OXYCODONE HYDROCHLORIDE CRS -* NARC (70 MG)

OXYCODONE HYDROCHLORIDE CRS -* NARC (70 MG)

124-90-3

DISCOVER
PHLOROGLUCINOL (ANHYDROUS) CRS (220 MG)

PHLOROGLUCINOL (ANHYDROUS) CRS (220 MG)

108-73-6

DISCOVER
RUSCOGENINS CRS (10 MG)

RUSCOGENINS CRS (10 MG)

472-11-7

DISCOVER
TRANDOLAPRIL IMPURITY C CRS (10 MG)

TRANDOLAPRIL IMPURITY C CRS (10 MG)

NA

DISCOVER
TRANDOLAPRIL IMPURITY D CRS (10 MG)

TRANDOLAPRIL IMPURITY D CRS (10 MG)

NA

DISCOVER
TROXERUTIN CRS (20 MG)

TROXERUTIN CRS (20 MG)

7085-55-4

DISCOVER
Tylosin phosphate for peak identification 10 mg

Tylosin phosphate for peak identification 10 mg

1401-69-0

DISCOVER
CALCIPOTRIOL (ANHYDROUS) - REFERENCE SPECTRUM (N/A)

CALCIPOTRIOL (ANHYDROUS) - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
ACARBOSE CRS (100 MG)

ACARBOSE CRS (100 MG)

56180-94-0

DISCOVER